Загрузка...
Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3
PURPOSE: Oral nitisinone has been shown to increase fur and ocular pigmentation in a mouse model of oculocutaneous albinism (OCA) due to hypomorphic mutations in tyrosinase (TYR), OCA1B. This study determines if nitisinone can improve ocular and/or fur pigmentation in a mouse model of OCA type 3 (OC...
Сохранить в:
| Опубликовано в: : | Invest Ophthalmol Vis Sci |
|---|---|
| Главные авторы: | , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Association for Research in Vision and Ophthalmology
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6181301/ https://ncbi.nlm.nih.gov/pubmed/30347088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.16-20293 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|